USPTO serial 79219912
IMMIPRINT
Reviewed by CopyMark Law Group
Reg. 5766272Status 414Registered
- Filing date
- Status date
- Registration date
- Jun 4, 2019
- Examiner
- JOHNSON, CLINTON J
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with IMMIPRINT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lori S. Meddings
Lori S. Meddings Quarles & Brady LLP33 East Main Street, Suite 900Madison, WI 53703UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Laboratory apparatus and equipment for use in the detection of soluble Cluster of Differentiation (CD) antigens, soluble immune system proteins, other soluble proteins in bodily fluids, and other soluble proteins in bodily fluids, namely, cytokines, all for research, diagnosis and monitoring of human and animal diseases and for the research and monitoring of treatments and therapies for human and animal diseases, namely, microplate readers, antibody bio-chips, flow cytometers, immuno detectors, microfluidic bio-chips, photometers, piezo electrical transducers, acoustic detectors and mass spectrometers; scientific apparatus and equipment for research purposes for use in the detection of soluble CD antigens, soluble immune system proteins, other soluble proteins in bodily fluids, and other soluble proteins in bodily fluids, namely, cytokines, all for use in the research of human and animal diseases and for the research of treatments and therapies for human and animal diseases, namely, microplate readers, antibody bio-chips, flow cytometers, immuno detectors, microfluidic bio-chips, photometers, piezo electrical transducers, acoustic detectors and mass spectrometers; measuring apparatus and instruments for use in connection with the research, diagnosis and monitoring of human and animal diseases and for the research and monitoring of treatments and therapies for human and animal diseases; computer software for receiving, processing, collating, analysing, transmitting, displaying and storing information and data, in connection with the research and diagnosis of human and animal diseases and for the monitoring of treatments and therapies for human and animal diseases; machine readable data carriers for use in connection with the research, diagnosis and monitoring of human and animal diseases and for the research and monitoring of treatments and therapies for human and animal diseases; data storage media for use with computers, namely, high speed computer storage sub-systems for storage and backup of electronic data either locally or via a telecommunications network, for receiving, processing, collating, analysing, transmitting, displaying and storing information and data, in connection with the research, diagnosis and monitoring of human and animal diseases and for the research and monitoring of treatments and therapies for human and animal diseases | SECTION 70 - CANCELLED | — |
| 010 | Apparatus for clinical, medical and veterinary diagnosis, namely, reagent panels, microplate readers for blood and body fluid based diagnostic testing, antibody bio-chips for blood and body fluid based diagnostic testing, flow cytometers for blood and body fluid based diagnostic testing, immuno detectors for blood and body fluid based diagnostic testing, microfluidic biochips for blood and body fluid based diagnostic testing, photometers for blood and body fluid based diagnostic testing, piezo electrical transducers for blood and body fluid based diagnostic testing, acoustic detectors and mass spectrometers for blood and body fluid based diagnostic testing; medical and veterinary testing apparatus for diagnosing human and animal diseases, in particular ones containing chemical and/or biochemical reagents, namely, reagent panels, microplate readers for blood and body fluid based diagnostic testing, antibody bio-chips for blood and body fluid based diagnostic testing, flow cytometers for blood and body fluid based diagnostic testing, immuno detectors for blood and body fluid based diagnostic testing, microfluidic bio-chips for blood and body fluid based diagnostic testing, photometers for blood and body fluid based diagnostic testing, piezo electrical transducers for blood and body fluid based diagnostic testing, acoustic detectors and mass spectrometers for blood and body fluid based diagnostic testing; apparatus and instruments for medical and clinical analysis diagnosis for use in the detection of soluble CD antigens, soluble immune system proteins, other soluble proteins in bodily fluids, and other soluble proteins in bodily fluids, namely, cytokines, all for use in the diagnosis and monitoring of human and animal diseases and for the monitoring of treatments and therapies for human and animal diseases, namely, reagent panels, microplate readers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, antibody biochips for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, flow cytometers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, immuno detectors for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring and predicting response to treatments and therapies, and patient stratification, microfluidic bio-chips for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring and predicting response to treatments and therapies, and patient stratification, photometers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring and predicting response to treatments and therapies, and patient stratification, piezo electrical transducers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring and predicting response to treatments and therapies, and patient stratification, acoustic detectors and mass spectrometers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring and predicting response to treatments and therapies, and patient stratification | SECTION 70 - CANCELLED | — |
| 042 | Scientific research; bacteriological research; biochemical research and development; biological research; clinical research in the nature of providing medical and scientific research information in the field of biomarker signature discovery and immune system response based diagnostics and proteomic diagnostics; medical research, biomedical research services; chemical research and analysis services in the nature of providing medical and scientific research information in the field of biomarker signature discovery and immune system response based diagnostics and proteomic diagnostics; genetic research in the nature of providing medical and scientific research information in the field of biomarker signature discovery and immune system response based diagnostics and proteomic diagnostics; design services in the field of biomarker signature discovery and immune system response based diagnostics and proteomic diagnostics | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ProteinLogic Limited
- Other trademarks owned by ProteinLogic Limited
- Other trademarks owned by ProteinLogic Limited
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named IMMIPRINT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 29, 2022 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Dec 29, 2022 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Sep 10, 2022 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Oct 4, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 18, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 18, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 4, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 4, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 19, 2019 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 3, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 3, 2019 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 19, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 19, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 15, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 27, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 27, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 27, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 14, 2019 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 13, 2019 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Feb 13, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 13, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 13, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 13, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 13, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 1, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 1, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 29, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jan 24, 2019 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 24, 2019 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Jan 24, 2019 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Jan 24, 2019 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Jul 24, 2018 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 24, 2018 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 27, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 27, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 27, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 19, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 28, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 28, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 14, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 13, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 11, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 10, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 6, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 2, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |